<DOC>
	<DOCNO>NCT01327170</DOCNO>
	<brief_summary>The aim study evaluate safety therapeutic response micropulse diode 810nm laser treatment patient chronic central serous chorioretinopathy .</brief_summary>
	<brief_title>Micropulse Diode Laser Treatment Chronic Central Serous Chorioretinopathy</brief_title>
	<detailed_description>Most case central serous chorioretinopathy ( CSC ) recur spontaneously within three month disease . After 3 month without resolution acute CSC chronic CSC , continuous wave laser photocoagulation photodynamic therapy consider . Direct threshold continuous photocoagulation treatment shorten duration serous detachment , appropriate juxtafoveal subfoveal leakage point.Subvisible photocoagulation potentially localize decrease chorioretinal thermic burn . Subthreshold diode micropulse ( SDM ) laser use 810nm diode laser may spare damage neural retina raise temperature RPE protein-denaturation threshold thermal wave reach neural retina insufficient cause neither damage clinically visible end-point . This therapeutic laser modality offer possibility minimize iatrogenic retinal lesion .</detailed_description>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>Chronic active central serous chorioretinopathy last 6 month Leakage fluorescein angiogram Opacities clear refractive medium eye Any intraocular surgery within 6 month prior study entry Prior vitrectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>